Evolus logo

Press Releases

Press Releases
Oct 29, 2020
Q3 2020 Net Revenue of $17.7 Million ; 34 Percent Increase Over Q3 2019 Cash 1 Position Increased Over Q2 2020 to $110.1 Million   NEWPORT BEACH, Calif. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on
Sep 08, 2020
NEWPORT BEACH, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that members of management will be participating in three upcoming virtual investor
Jul 06, 2020
Pro Forma Cash¹ Position of $125 Million at June 30, 2020 NEWPORT BEACH, Calif. , July 06, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced that its strategic partner, Daewoong Pharmaceutical Co. Ltd., will invest $40 million in a five-year, unsecured, subordinated, 3%
May 11, 2020
NEWPORT BEACH, Calif. , May 11, 2020 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today reported financial results for the first quarter ended March 31, 2020 and provided a business
Displaying 1 - 10 of 18